SCHEMBL2354125

SCHEMBL2354125

CCCCC/C=C/CC(O)CCCCCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 1.00
▸ FFAR4 Q5NUL3 2/20 1.00
▸ FAAH O00519 3/20 0.76
▸ NFKB1 P19838 1/20 0.74
▸ NFKB2 Q00653 1/20 0.74
▸ RELA Q04206 1/20 0.74
▸ TERT O14746 3/20 0.70
▸ PTPN1 P18031 3/20 0.70
▸ PPARG P37231 3/20 0.70
▸ PPARD Q03181 3/20 0.70
▸ PPARA Q07869 3/20 0.70
▸ MAPT P10636 2/20 0.70
▸ BLM P54132 2/20 0.70
▸ HSD17B10 Q99714 2/20 0.70
▸ FABP4 P15090 2/20 0.70
▸ F7 P08709 2/20 0.70
▸ F3 P13726 2/20 0.70
▸ DUSP3 P51452 2/20 0.70
▸ PTPN7 P35236 2/20 0.70
▸ GMNN O75496 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9721104 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL3699513 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL17518703 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
Ricinoleic Acid SCHEMBL25248998 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL291095 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL23925390 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL23925391 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
Ricinoleic Acid SCHEMBL23532631 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL22400911 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL9401994 1.00 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118063661-B Ion exchange resin and purification process of acrylamide crude product 富淼科技(如东)有限公司 2025-06-24 — — CN claimed
WO-2025049879-A1 THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS OF USE THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2025-03-06 — — WO claimed
CN-118726528-A Hydroxy fatty acid sterol ester and preparation method and application thereof 北京化工大学 2024-10-01 — — CN claimed
CN-118063661-A Ion exchange resin and purification process of acrylamide crude product 南通博亿化工有限公司 2024-05-24 — — CN claimed
WO-2024063611-A2 LONG-CHAIN FATTY ACID OR DERIVATIVE THEREOF FOR STRONGLY ACTIVATING FATTY ACID RECEPTOR 박진병 2024-03-28 — — WO claimed
WO-2023063175-A1 HYDROGENATION FLAVOR-IMPARTING AGENT AND METHOD FOR PRODUCING SAME, METHOD FOR IMPARTING HYDROGENATION FLAVOR TO FOOD, USE OF OXIDIZED PRODUCT FOR IMPARTING HYDROGENATION FLAVOR TO FOOD, AND FOOD CONTAINING HYDROGENATION FLAVOR-IMPARTING AGENT 株式会社J-オイルミルズ 2023-04-20 — — WO claimed
EP-3707268-A1 ENZYMATIC METHOD FOR FORMING ESTOLIDES Produits Chimiques Auxiliaires et de Synthese (FR) 2020-09-16 — — EP claimed
EP-2893026-B1 PROCESS FOR PREPARING SEBACIC ACID BASF SE (DE) 2018-08-01 — — EP claimed
US-9834798-B2 Process for preparing sebacic acid BASF SE (DE) 2017-12-05 — — US claimed
US-20150259713-A1 PROCESS FOR PREPARING SEBACIC ACID BASF SE (DE) 2015-09-17 — — US claimed
EP-2893026-A1 PROCESS FOR PREPARING SEBACIC ACID BASF SE (DE) 2015-07-15 — — EP claimed
WO-2014037328-A1 PROCESS FOR PREPARING SEBACIC ACID BASF SE (DE) 2014-03-13 — — WO claimed
EP-2706117-A1 Process for preparing sebacic acid BASF SE (DE) 2014-03-12 — — EP claimed
US-20110206802-A1 BIODEGRADABLE CHEWING GUM BASES AND USES THEREOF FLYNN ALLISON 2011-08-25 — — US claimed
WO-2010053908-A1 BIODEGRADABLE CHEWING GUM BASES AND USES THEREOF FLYNN ALLISON (US) 2010-05-14 — — WO claimed
US-12522686-B2 Method for producing hydroxy-fatty-acid-based polyols U. WINDMÖLLER INNOVATION GMBH & CO. KG (DE) 2026-01-13 — — US disclosed
US-20250261673-A1 NATURAL LACTONES AND HYDROXY FATTY ACIDS AND METHODS OF MAKING SAME INTERNATIONAL FLAVORS & FRANGRANCES INC. 2025-08-21 — — US disclosed
EP-0578388-A2 Fermentation process for preparing 10-hydroxy-C18-carboxylic acid and gamma-dodecalactone derivatives INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1994-01-12 — — EP disclosed
EP-0230043-A2 Process for hydration of unsaturated carboxylic acids FORSCHUNGSZENTRUM JÜLICH GMBH (DE) 1987-07-29 — — EP disclosed
US-4582804-A RHODOCOCCUS HYDRATION OF UNSATURATED FATTY ACIDS UNION CAMP CORPORATION 1986-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259713-A1 PROCESS FOR PREPARING SEBACIC ACID SCD, ALOX12, ALOX15 FFAR1 168/4885FFAR4 615/4885FAAH 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback